Nitrogen-containing saturated heterocyclyl derivative
AssigneeSumitomo Pharma Co., Ltd.
InventorsHitoshi WATANABE, Shuya YAMADA, Katsushi KITAHARA, Mariko KOBAYASHI
Life of this patent
Estimating the term…
Loading patent…
AssigneeSumitomo Pharma Co., Ltd.
InventorsHitoshi WATANABE, Shuya YAMADA, Katsushi KITAHARA, Mariko KOBAYASHI
Estimating the term…
The present invention relates to a medicament for treating or preventing central nervous system disease whose cause is related to abnormal aggregation of proteins in the brain, which comprises as an active ingredient a compound of formula (1) or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are hydrogen, etc., R3 and R4 are hydrogen, C1-6 alkyl, etc., R5 is halogen, C1-6 alkyl, etc., R6 is hydrogen, halogen, etc., X is oxygen, etc., Y is carbon, etc., m and n are an integer of 0, 1, etc., r and s are 0, 1, 2, etc., Hy is pyridine ring, etc., which has an action of suppressing or reducing the accumulation of abnormal aggregation of proteins in the brain.
1:
2:
3:
4:
5:
6:
7:
8:
9:
10:
11:
12:
13:
14:
15:
16:
17:
18:
19:
20:
21:
22:
23:
24:
25:
26:
27:
28:
29:
30:
31:
32:
33:
34:
35:
36:
37:
38:
39:
40:
41:
42:
43:
44:
45:
46:
47: